Objectives: 

Breast:

1. Review the role of genomic testing in ER+ breast cancer.

2. Review data from TAILORx trial. 

3. Review additional relevant ASCO presentations.

Gastrointestinal:  Provide updates to evidence-based management options. 

Gynecologic: 

1. To review outcomesin recurrent uterine and ovarian cancer with both traditional chemotherapy and targeted agents. 

2. To review most recent data on chemotherapy in rare gynecologic tumors.